相关实验视频

Updated: Jan 15, 2026

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

ApoA1/HDL和败血症相关的血管内皮损伤:一个叙述性回顾

Kailin Guo^1,2, Chang Hu^1,2, Le Li^1,2

¹Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China.

Critical care (London, England)

|October 9, 2025

概括

败血症通过内皮损伤导致死亡,与低Apolipoprotein A1 (ApoA1) /高密度脂蛋白 (HDL) 有关. 这篇综述表明ApoA1/HDL积极保护内皮细胞,并提供治疗潜力.

科学领域:

败血症的病理生理学
内皮细胞生物学内皮细胞生物学
脂蛋白代谢的代谢脂蛋白代谢

背景情况:

败血症是导致死亡的主要原因,其特点是微血管崩和内皮损伤.
Apolipoprotein A1 (ApoA1) 和高密度脂蛋白 (HDL) 的耗尽是败血症引起的内皮损伤的关键特征.
在败血症中ApoA1/HDL轴的作用尚未完全理解,这限制了治疗的发展.

研究的目的:

系统地审查和综合有关败血症ApoA1/HDL轴的证据.
将ApoA1/HDL轴重新定义为内皮恒温的主调节器,而不仅仅是生物标志物.
探索针对ApoA1/HDL轴治疗败血症的治疗潜力.

主要方法:

系统的文献综述研究调查ApoA1/HDL在败血症的研究.
分析ApoA1/HDL水平与内皮损伤之间的相关性.
检查ApoA1/HDL介导的内皮细胞保护背后的机制.
基于ApoA1的治疗策略的评估.

主要成果:

降低的ApoA1/HDL水平与败血症中的内皮损伤有很强的相关性.
ApoA1/HDL轴通过抗炎作用,屏障完整性保护和微血管流量恢复来发挥保护作用.
新出现的证据强调了ApoA1在外体介导调节中的作用.
ApoA1模仿性和重组性HDL显示了翻译潜力.

结论:

ApoA1 / HDL轴是败血症中内皮恒温的关键,活跃的调节器.
针对ApoA1/HDL轴提供了一种有前途的败血症治疗策略.
对基于ApoA1的治疗方法的进一步研究可能会导致新的内皮为中心的败血症治疗方法.

关键词:

阿波利波蛋白A1 (ApoA1) 是一种蛋白质.外基因组是外基因组的组成部分.高密度脂蛋白 (HDL) 是一种高密度脂蛋白.败血症这是一种败血症.血管内皮损伤血管内皮损伤

更多相关视频

Stimulation of Vascular Endothelial Cells Using Neutrophil Extracellular Traps in the Presence of Low-Density Lipoprotein

Stimulation of Vascular Endothelial Cells Using Neutrophil Extracellular Traps in the Presence of Low-Density Lipoprotein

Published on: August 12, 2025

A Modified Surgical Model of Hind Limb Ischemia in ApoE-/- Mice using a Miniature Incision

A Modified Surgical Model of Hind Limb Ischemia in ApoE-/- Mice using a Miniature Incision

Published on: May 13, 2021

相关概念视频

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

Peripheral Artery Disease I: Introduction

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...

Ischemic Heart Disease: Overview

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...